Drugs Policy

Debate between Norman Lamb and Crispin Blunt

Tuesday 18th July 2017 Commons Chamber

[Crispin Blunt]

I wholly agree. If the evidence of failure is clear in the United Kingdom, the problem is dramatically worse in other countries of the world. However, even in the UK, as page 16 of the strategy makes clear, drugs are

“a significant threat to our national security.”

There is a way of dealing with the problem.

Ever since prohibition or criminalisation of illicit drug use was enshrined in the 1961 UN convention on narcotic drugs, we have been fighting a losing battle to stem the global drugs trade. As is increasingly recognised—especially in Latin America, where many leaders are crying out for their societies to be rescued from the malign fall-out from a multi-billion dollar criminal industry—eradication, interdiction and criminalisation of consumption have failed. We have left the manufacture and supply in the hands of organised criminals and treated their victims—many of whom are vulnerable members of our society and many of whom have mental illnesses—as criminals, and they are unable or unwilling to seek medical help due to the illegality, exclusion and stigma.

I hope that hon. Members will reflect on this simple statistic: between 2006 and 2013, 111,000 people died in the Mexican drug war—as a result not of drug consumption, but of the wars over the control of this vast industry. Building on the work of the Latin American Commission on Drugs and Democracy, convened by former Presidents of Brazil, Colombia and Mexico, the Global Commission on Drug Policy has opened a public discussion about the association between the drug trade, violence and corruption.

[Norman Lamb]

I agree with everything that the hon. Gentleman has said. He has talked about the number of people who have lost their lives through violence in Latin America. Does he agree that the policy engenders violence in our own communities—particularly poor communities—in this country? The only way in which the supply to a particular community can be maintained is through the use of extreme violence. Does that not add to the case for much needed reform?

[Crispin Blunt]

Unsurprisingly, I agree entirely with the right hon. Gentleman.

NHS Commissioning Board

Debate between Norman Lamb and Crispin Blunt

Tuesday 5th March 2013 Commons Chamber

[Norman Lamb]

The right hon. Gentleman’s own Government had guidance in place precisely to address anti-competitive behaviour. Let me again reiterate that these regulations will not introduce compulsory competitive tendering. The amendments that we will table will make it absolutely clear that the power rests with clinical commissioning groups, and not with the Government, Monitor or anyone else.

[Mr Crispin Blunt (Reigate) (Con)]

My hon. Friend will have heard the charge of audacity from the shadow Health Secretary, whose expertise and qualities in this area should be acknowledged to place him in a league of his own. If there is still no clarity on the competitive position, which has not moved on from that of the last Administration, the responsibility lies precisely over there, on the Opposition Benches.

[Norman Lamb]

I take the point, but I again reiterate that the rules and guidelines for commissioners will remain exactly as they were under the last Government and under the right hon. Member for Leigh as Secretary of State.